227 related articles for article (PubMed ID: 12656810)
1. Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides.
Sadick NS; Herman AR
Dermatol Surg; 2003 Apr; 29(4):340-7. PubMed ID: 12656810
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
Dessy LA; Fallico N; Mazzocchi M; Scuderi N
Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
[TBL] [Abstract][Full Text] [Related]
3. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
Matarasso SL
Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type B.
Sadick NS
Dermatol Surg; 2003 Apr; 29(4):348-50; discussion 350-1. PubMed ID: 12656811
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
Alster TS; Lupton JR
Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
Yamauchi PS; Lowe NJ
Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
[TBL] [Abstract][Full Text] [Related]
8. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
Sadick NS; Faacs
Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin-B and the management of hyperhidrosis.
Baumann LS; Halem ML
Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
[TBL] [Abstract][Full Text] [Related]
11. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
Sadick NS
Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
[TBL] [Abstract][Full Text] [Related]
12. Comparison of botulinum toxins A and B in the treatment of facial rhytides.
Sadick NS; Matarasso SL
Dermatol Clin; 2004 Apr; 22(2):221-6. PubMed ID: 15222583
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin for the treatment of major depressive disorder].
Hawlik AE; Freudenmann RW; Pinkhardt EH; Schönfeldt-Lecuona CJ; Gahr M
Fortschr Neurol Psychiatr; 2014 Feb; 82(2):93-9. PubMed ID: 24519192
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety.
Roger Aoki K
Toxicon; 2002 Jul; 40(7):923-8. PubMed ID: 12076646
[TBL] [Abstract][Full Text] [Related]
16. Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections.
Dubow J; Kim A; Leikin J; Cumpston K; Bryant S; Rezak M
Mov Disord; 2005 Jul; 20(7):877-80. PubMed ID: 15806568
[TBL] [Abstract][Full Text] [Related]
17. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
Lowe NJ; Shah A; Lowe PL; Patnaik R
J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
[TBL] [Abstract][Full Text] [Related]
18. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
Houser MK; Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin type B--a rapid wrinkle reducer.
Jacob CI
Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232
[TBL] [Abstract][Full Text] [Related]
20. The cosmetic use of botulinum toxin type B in the upper face.
Sadick NS
Clin Dermatol; 2004; 22(1):29-33. PubMed ID: 15158542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
